NORDIC TUMOREX— 510(k) K123306

Substantially Equivalent

Nordicneurolab

FDA 510(k) clearance K123306 for NORDIC TUMOREX, Substantially Equivalent on 2013-05-20. Applicant: Nordicneurolab.

Clearance details

Applicant: Nordicneurolab
Product code: Code LLZ
Advisory panel: Radiology
Date received: 2012-10-24
Decision date: 2013-05-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bergen, Hordaland, NO

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.